QYN
LIVE

Serial Number

99929330

Owner

Qyn Labs, Inc

Attorney

Christina M. Licursi

Filing Date

Jul 8, 2026

Add to watchlist:

No watchlists yet
View on USPTO

QYN Trademark

Serial Number: 99929330

QYN is a trademark filed by Qyn Labs, Inc on July 8, 2026. The trademark is classified under Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently pending registration.

Owner Contact Info

Qyn Labs, Inc

42 Richardson Rd
Belmont, MA 02478

Entity Type: 03

Trademark Details

Filing Date

July 8, 2026

Registration Date

Not Registered

Goods & Services

Hormone testing kits comprised of medical diagnostic reagents and assay components for measuring hormone levels for medical purposes; medical diagnostic testing kits comprised of reagents and assay components for detecting and measuring biomarkers for medical purposes

Health and wellness services, namely, providing information and consulting in the field of hormonal health and balance; providing medical and health information based on analysis of biomarkers; providing clinical decision support services, namely, providing medical information and treatment recommendations based on biomarker data

Downloadable mobile application software for tracking, analyzing, and managing hormone-related health data; downloadable software for collecting, processing, and analyzing biomarker data, including patient health data; downloadable software featuring clinical decision support tools for use by clinicians, physicians, and healthcare providers in analyzing biomarker data and generating diagnostic and treatment recommendations; downloadable software for use by pharmaceutical companies in analyzing biomarker data for drug development and clinical research

Providing temporary use of non-downloadable software for analyzing hormone test data and generating reports; providing temporary use of non-downloadable software for analyzing biomarker data and generating reports; software as a service (SaaS) services featuring software for processing, aggregating, and interpreting patient biomarker data; providing temporary use of non-downloadable clinical decision support software for use by clinicians, physicians, and healthcare providers to analyze biomarker data and generate diagnostic and treatment recommendations; providing temporary use of non-downloadable software for use by pharmaceutical companies in biomarker analysis, drug development, and clinical trial optimization

Filing History

APPLICATION FILING RECEIPT MAILED
Jul 8, 2026 MAFR
NEW APPLICATION ENTERED
Jul 8, 2026 NWAP